Exane Derivatives’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $256K | Sell |
|
|||||
|
2022
Q1 | $710K | Buy |
|
|||||
|
2021
Q4 | $495K | Buy |
|
|||||
|
2021
Q3 | $404K | Buy |
|
|||||
|
2021
Q2 | $352K | Buy |
|
|||||
|
2021
Q1 | $261K | Sell |
|
|||||
|
2020
Q4 | $684K | Buy |
|
|||||
|
2020
Q3 | $165K | Sell |
|
|||||
|
2020
Q2 | $626K | Sell |
|
|||||
|
2020
Q1 | $744K | Sell |
|
|||||
|
2019
Q4 | $815K | Sell |
|
|||||
|
2019
Q3 | $731K | Buy |
|
|||||
|
2019
Q2 | $109K | Buy |
|
|||||
|
2019
Q1 | $119K | Sell |
|
|||||
|
2018
Q4 | $1.11M | Sell |
|
|||||
|
2018
Q3 | $1.28M | Sell |
|
|||||
|
2018
Q2 | $1.29M | Sell |
|
|||||
|
2018
Q1 | $1.26M | Sell |
|
|||||
|
2017
Q4 | $1.58M | Buy |
|
|||||
|
2017
Q3 | $54.4K | Sell |
|
|||||
|
2017
Q2 | $304K | Sell |
|
|||||
|
2017
Q1 | $451K | Sell |
|
|||||
|
2016
Q4 | $1.31M | Buy |
|
|||||
|
2016
Q3 | $71.8K | Sell |
|
|||||
|
2016
Q2 | $274K | Sell |
|
|||||
|
2016
Q1 | $423K | Buy |
|
|||||
|
2015
Q4 | $187K | Buy |
|